Salt la conţinut

Drepanocitoză

Managementul crizei vaso-ocluzive și a sindromului coronarian acut

Managementul durerii

What is the best pharmacologic treatment for sickle cell disease pain crises? (se deschide o fereastră nouă)

Baker M, Hafner JW.

Sursă‎: Ann Emerg Med 2012;59(6):515-6.

Index‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (se deschide o fereastră nouă)

Update on pain management in sickle cell disease. (se deschide o fereastră nouă)

Ballas SK.

Sursă‎: Hemoglobin 2011;35(5-6):520-9.

Index‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (se deschide o fereastră nouă)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (se deschide o fereastră nouă)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Sursă‎: Thromb Haemost 2007;98(2):392-6.

Index‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (se deschide o fereastră nouă)

Terapia prin hidratare (managementul fluidelor)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (se deschide o fereastră nouă)

Okomo U, Meremikwu MM.

Sursă‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Index‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (se deschide o fereastră nouă)

Suplimentarea oxigenului

Guidelines for the management of the acute painful crisis in sickle cell disease. (se deschide o fereastră nouă)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Sursă‎: Br J Haematol 2003;120(5):744-52.

Index‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (se deschide o fereastră nouă)

Antibiotic și tratament respiratoriu

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (se deschide o fereastră nouă)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Sursă‎: Hemoglobin 2004;28(2):85-102.

Index‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (se deschide o fereastră nouă)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (se deschide o fereastră nouă)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Sursă‎: N Engl J Med 1995;333(11):699-703.

Index‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (se deschide o fereastră nouă)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (se deschide o fereastră nouă)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Sursă‎: J Investig Med 2008;56(8):1023-7.

Index‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (se deschide o fereastră nouă)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (se deschide o fereastră nouă)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Sursă‎: N Engl J Med 2000;342(25):1855-65.

Index‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (se deschide o fereastră nouă)